APA (7th ed.) Citation

Uchida, Y., Inao, M., Tsuji, S., Uemura, H., Kouyama, J., Naiki, K., . . . Mochida, S. (2020). Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Hepatology research, 50(12), 1355-1364. https://doi.org/10.1111/hepr.13566

Chicago Style (17th ed.) Citation

Uchida, Yoshihito, et al. "Furosemide as a Factor to Deteriorate Therapeutic Efficacy of Tolvaptan in Patients with Decompensated Cirrhosis." Hepatology Research 50, no. 12 (2020): 1355-1364. https://doi.org/10.1111/hepr.13566.

MLA (9th ed.) Citation

Uchida, Yoshihito, et al. "Furosemide as a Factor to Deteriorate Therapeutic Efficacy of Tolvaptan in Patients with Decompensated Cirrhosis." Hepatology Research, vol. 50, no. 12, 2020, pp. 1355-1364, https://doi.org/10.1111/hepr.13566.